Directive 2010/84/EU
E1533649
UNEXPLORED
Directive 2010/84/EU is a European Union legislative act that significantly strengthened and modernized the EU pharmacovigilance system to improve the monitoring and safety of medicinal products for human use.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Directive 2010/84/EU canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T22404543 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Directive 2010/84/EU Context triple: [Directive 2001/83/EC, amendedBy, Directive 2010/84/EU]
-
A.
Directive 2010/53/EU
Directive 2010/53/EU is a European Union law that sets common standards for the quality and safety of human organs intended for transplantation across EU member states.
-
B.
Directive 2006/86/EC
Directive 2006/86/EC is a European Union legal act that sets detailed technical requirements for the traceability, notification of serious adverse reactions and events, and quality and safety standards for human tissues and cells used in medical treatments.
-
C.
Directive 2014/65/EU
Directive 2014/65/EU is a key European Union legislative act that overhauls and strengthens the regulatory framework for investment services and financial markets, commonly known as MiFID II.
-
D.
Directive 2001/83/EC
Directive 2001/83/EC is a key European Union law that sets the framework for the authorization, manufacture, distribution, and pharmacovigilance of medicinal products for human use across EU member states.
-
E.
Directive 2013/37/EU
Directive 2013/37/EU is a European Union law that updated and expanded the rules on the re-use of public sector information to promote transparency, innovation, and economic activity across the EU.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Directive 2010/84/EU Target entity description: Directive 2010/84/EU is a European Union legislative act that significantly strengthened and modernized the EU pharmacovigilance system to improve the monitoring and safety of medicinal products for human use.
-
A.
Directive 2010/53/EU
Directive 2010/53/EU is a European Union law that sets common standards for the quality and safety of human organs intended for transplantation across EU member states.
-
B.
Directive 2006/86/EC
Directive 2006/86/EC is a European Union legal act that sets detailed technical requirements for the traceability, notification of serious adverse reactions and events, and quality and safety standards for human tissues and cells used in medical treatments.
-
C.
Directive 2014/65/EU
Directive 2014/65/EU is a key European Union legislative act that overhauls and strengthens the regulatory framework for investment services and financial markets, commonly known as MiFID II.
-
D.
Directive 2001/83/EC
Directive 2001/83/EC is a key European Union law that sets the framework for the authorization, manufacture, distribution, and pharmacovigilance of medicinal products for human use across EU member states.
-
E.
Directive 2013/37/EU
Directive 2013/37/EU is a European Union law that updated and expanded the rules on the re-use of public sector information to promote transparency, innovation, and economic activity across the EU.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.